Home/Biomosaics/Ronald D. Guttmann, MD, FRCPC
RD

Ronald D. Guttmann, MD, FRCPC

Director

Biomosaics

Therapeutic Areas

Biomosaics Pipeline

DrugIndicationPhase
CanAg® Glypican-3 EIADetection of soluble GPC3 in serum/plasmaCommercial
Glypican-3 Antibodies for IHCDetection of GPC3 in tissue samplesCommercial
Glypican-3 Immunohistochemistry KitsDetection of GPC3 in tissue samplesCommercial